ONCODEcipher Liquid28 NGS Panel
Non-invasive cell free circulating tumour DNA (ctDNA) panel that delivers information on a variety of treatment/prognosis informative mutations in the 28 genes which are known to play a role in of solid tumours using only the blood of the patients.
Highlighted Genes -- EGFR, BRAF, KRAS, ESR1, FGFR, PIK3CA, TP53, ALK resistance etc.
Next Generation Sequencing (NGS)
Cell free DNA extracted from plasma is subjected to amplification-based library preparation and massively parallel sequencing. Sequencing analysis is performed using commercial bioinformatics pipelines and annotation is done using proprietary and public databases.
15ml Blood in cfDNA tubes
Turn Around Time:
10 working days
Keep specimen at room temperature. DO NOT ship on ice or dry ice or expose to direct sunlight.